By Ethan Covey
The introduction of a rubella-containing vaccine (RCV) into the routine immunization program of countries that have not introduced RCV would prevent an estimated 986,000 cases of congenital rubella syndrome (CRS) in the next 30 years, according to a modeling study.
Because of widespread use of the measles, mumps and rubella vaccine, rubella has been pushed to very low levels in the United States. However, by the end of 2023, 19 lower- and middle-income countries had not yet